天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate

(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate Struktur
CAS-Nr.
Englisch Name:
(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate
Synonyma:
Rosuvastatin calcium impurity 49;(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate
CBNumber:
CB19739522
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate Eigenschaften

Sicherheit

(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate Chemische Eigenschaften,Einsatz,Produktion Methoden

(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
sales@bjcomparison.com China 4717 58
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
2880679888@qq.com China 3006 58
Wuxi Helen Biotechnology Co., Ltd., 0510-85629785 18013409632
sales@reading-chemicals.com China 14081 58

  • (3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate
  • Rosuvastatin calcium impurity 49
Copyright 2019 ? ChemicalBook. All rights reserved